226
|
Kammerlander A, Marzluf B, Bonderman D, Nikfardjam M, Graf A, Maurer G, Mascherbauer J. PRESENCE OF TRICUSPID REGURGITATION AFTER LEFT–HEART VALVE SURGERY INDEPENDENTLY PREDICTS MORTALITY. J Am Coll Cardiol 2013. [DOI: 10.1016/s0735-1097(13)61988-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
227
|
Karakus G, Marzluf BA, Bonderman D, Babayev J, Tufaro C, Pfaffenberger S, Maurer G, Mascherbauer J. Epicardial fat volume is inversely correlated with the degree of diastolic dysfunction and outcome in patients with heart failure with preserved ejection fraction. J Cardiovasc Magn Reson 2013. [PMCID: PMC3559893 DOI: 10.1186/1532-429x-15-s1-p268] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
228
|
Neuhold S, Huelsmann M, Pernicka E, Graf A, Bonderman D, Adlbrecht C, Binder T, Maurer G, Pacher R, Mascherbauer J. Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study. Eur Heart J 2013; 34:844-52. [DOI: 10.1093/eurheartj/ehs465] [Citation(s) in RCA: 115] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
229
|
Marzluf BA, Bonderman D, Tufaro C, Pfaffenberger S, Graf A, Hülsmann M, Lang IM, Pacher R, Maurer G, Mascherbauer J. Diffuse myocardial fibrosis by post-contrast T1-time predicts outcome in heart failure with preserved ejection fraction. J Cardiovasc Magn Reson 2013. [PMCID: PMC3559521 DOI: 10.1186/1532-429x-15-s1-m6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
230
|
Bonello B, Kempny A, Uebing A, Li W, Kilner P, Diller G, Pennell D, Ernst S, Shore D, Babu-Narayan S, Bonanad Lozano C, Monmeneu J, Lopez-Lereu M, Chaustre F, Sanchis J, Nunez J, Chorro F, Bodi V, Vancraeynest D, Roelants V, Hanin F, Morrison M, Pasquet A, Gerber B, Bol V, Bol A, Bouzin C, Vanoverschelde J, Marzluf BA, Bonderman D, Pfaffenberger S, Ringelspacher E, Huelsmann M, Tufaro C, Lang I, Maurer G, Pacher R, Mascherbauer J, Hrynchyshyn N, Azarine A, Samadi A, Perdrix L, Khedim-Touati R, Mousseaux E, Diebold B. Oral Abstract Sessions * Multimodality Imaging - MRI CT and Nuclear Cardiology Abstract Session: Nuclear cardiology. Eur Heart J Cardiovasc Imaging 2012. [DOI: 10.1093/ehjci/jes252] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
231
|
Montoro Lopez M, Iniesta Manjavacas A, De Torres Alba F, Lopez Fernandez T, De Celix MCGR, Gomez De Diego J, Ramirez U, Mesa J, Moreno Yanguela M, Lopez Sendon J, Shiina Y, Ernst S, Gatzoulis M, Li W, Cameli M, De Vito R, Di Giovanni A, Lisi M, Focardi M, Giacomin E, Bigio E, Mondillo S, Szymczyk E, Lipiec P, Michalski B, Szymczyk K, Rotkiewicz A, Wozniakowski B, Stefanczyk L, Kasprzak J, Luo X, Fang F, Lee AP, Lam Y, Sanderson JE, Kwong JS, Yu C, Nasis A, Moir S, Meredith I, Mottram P, Van Zalen J, Podd S, Raju P, Mcintosh R, Beale L, Brickley G, Sturridge L, Patel N, Lloyd G, Esteban Martinez F, Ariza Canete J, Casanova Martin M, Ciudad Caballero M, Trapiello Gonzalez L, Herrera Gutierrez N, Matei F, Beladan C, Popescu B, Calin A, Rosca M, Curea F, Calin C, Ginghina C, Baronaite-Dudoniene K, Vaskelyte JJ, Puodziukynas A, Smalinskas V, Urbonaite L, Botezatu CD, Enache R, Rosca M, Beladan CC, Calin A, Gurzun MM, Ginghina C, Popescu BA, Ercan S, Kervancioglu S, Davutoglu V, Cakici M, Ozkur A, Oylumlu M, Sari I, Faustino A, Paiva L, Providencia R, Trigo J, Botelho A, Costa M, Leitao-Marques A, Al Barjas M, Alwis L, Sonoda L, Balan K, Alqaseer M, Jelani A, Niaz K, Andres Lahuerta A, Igual Munoz B, Alonso Fernandez P, Maceira A, Cano O, Osca J, Sancho-Tello M, Jimenez Carreno R, De Munoz YR, De Ros JO, Bonanad Lozano C, Lopez-Lereu M, Monmeneu J, Estornell J, Igual Munoz B, Maceira A, Chaustre F, Sanchis J, Badr Eslam R, Pfaffenberger S, Marzluf B, Frey M, Bartko P, Babayev J, Kammerlander A, Maurer G, Mascherbauer J. Club 35 Poster session Friday 7 December: Dobutamine stress echo. Eur Heart J Cardiovasc Imaging 2012. [DOI: 10.1093/ehjci/jes262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
232
|
Tufaro C, Mascherbauer J, Marzluf B, Binder T, Lang I, Bonderman D. Prognoseparameter bei Herzinsuffizienz mit erhaltener Linksventrikelfunktion. Pneumologie 2012. [DOI: 10.1055/s-0032-1309169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
233
|
Adlbrecht C, Andreas M, Redwan B, Distelmaier K, Mascherbauer J, Kaider A, Wolzt M, Tilea IA, Neunteufl T, Delle-Karth G, Maurer G, Lang IM. Systemic endothelin receptor blockade in ST-segment elevation acute coronary syndrome protects the microvasculature: a randomised pilot study. EUROINTERVENTION 2012; 7:1386-95. [DOI: 10.4244/eijv7i12a218] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
234
|
Mascherbauer J, Fuchs C, Pernicka E, Wollenek G, Rosenhek R, Bonderman D, Maurer G, Baumgartner H. Predictors of outcome of non-ischemic mitral valve surgery. Int J Cardiol 2011; 165:87-92. [PMID: 21862149 DOI: 10.1016/j.ijcard.2011.07.088] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/23/2011] [Revised: 07/08/2011] [Accepted: 07/26/2011] [Indexed: 11/25/2022]
Abstract
BACKGROUND Data on the risk stratification of patients undergoing mitral valve (MV) surgery for non-ischemic mitral disease are sparse. The present study seeks to define them in a contemporary cohort. METHODS 193 consecutive patients referred to non-ischemic MV surgery were prospectively studied. Baseline characteristics and the type of surgery were analyzed with regard to operative and late mortality as well as functional outcome. RESULTS 129 patients underwent MV replacement and 64 MV repair. MV replacement patients presented with more symptoms (p = 0.010), higher EuroSCORE (6.1 versus 5.6; p=0.009), more frequently underwent additional valve surgery (7.8 versus 0%; p = 0.003) and were more frequently female (p=0.048). Operative mortality was 3.1%, two thirds of operative deaths had additional surgery of the tricuspid valve (p = 0.019). Patients were followed for 5.2 ± 2.7 years. 1-, 3-, 5- and 7-year survival rates were 93-, 91-, 82-, and 79% in MV replacement patients versus 100-, 98-, 96-, and 89% in patients with MV repair (p = 0.015). However, by multivariate logistic regression, overall mortality was determined by additional surgery of the tricuspid valve (p = 0.0103), multivessel coronary disease (p = 0.026), and age (p<0.0001), but not by the type of surgery (p=0.066). Furthermore, the type of surgery did not influence functional outcome (p = 0.515). CONCLUSIONS Apart from age and coronary artery disease the need for additional tricuspid valve surgery significantly determines the outcome of non-ischemic MV surgery. The type of operation appears less important when the need for additional valve surgery and co-morbidities like coronary artery disease are taken into consideration.
Collapse
|
235
|
Kempny A, Diller GP, Orwat S, Kaleschke G, Kerckhoff G, Schmidt R, Mascherbauer J, Reinecke H, Baumgartner H. TRANSCATHETER AORTIC VALVE IMPLANTATION IS NOT ASSOCIATED WITH A DETRIMENTAL EFFECT ON RIGHT VENTRICULAR FUNCTION AS OBSERVED AFTER SURGICAL AORTIC VALVE REPLACEMENT. J Am Coll Cardiol 2011. [DOI: 10.1016/s0735-1097(11)61373-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
236
|
Kempny A, Diller GP, Orwat S, Kaleschke G, Kerckhoff G, Schmidt R, Mascherbauer J, Reinecke H, Baumgartner H. PRE-INTERVENTIONAL LEFT VENTRICULAR 2D STRAIN PREDICTS THE RECOVERY OF MYOCARDIAL DYSFUNCTION AND IMPROVEMENT IN FUNCTIONAL CAPACITY AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION. J Am Coll Cardiol 2011. [DOI: 10.1016/s0735-1097(11)61375-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
237
|
Mascherbauer J, Fuchs C, Baumgartner H. The Authors' reply. BRITISH HEART JOURNAL 2011. [DOI: 10.1136/hrt.2010.210336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
238
|
Calin A, Popescu BA, Beladan CC, Rosca M, Muraru D, Lupascu L, Calin C, Jurcut R, Sandu C, Ginghina C, Rosca M, O'Connor K, Romano G, Magne J, Calin A, Popescu BA, Beladan CC, Pierard L, Ginghina C, Lancellotti P, Attias D, Dreyfus J, Brochet E, Berjeb N, Cueff C, Cimadevilla C, Lepage L, Iung B, Vahanian A, Messika-Zeitoun D, Kempny A, Diller GP, Orwat S, Kaleschke G, Kerckhoff G, Radke RM, Schmidt R, Mascherbauer J, Reinecke H, Baumgartner H, Di Bello V, Giannini C, Talini E, De Carlo M, Delle Donne MG, Guarracino F, Nardi C, Dini FL, Marzilli M, Petronio AS. Oral session V: New Insights on left ventricular function in aortic stenosis * Friday 10 December 2010, 08:30-10:00. EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY 2010. [DOI: 10.1093/ejechocard/jeq139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
239
|
Mascherbauer J, Maurer G. The forgotten valve: lessons to be learned in tricuspid regurgitation. Eur Heart J 2010; 31:2841-3. [DOI: 10.1093/eurheartj/ehq303] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
240
|
Fuchs C, Mascherbauer J, Rosenhek R, Pernicka E, Klaar U, Scholten C, Heger M, Wollenek G, Czerny M, Maurer G, Baumgartner H. Gender differences in clinical presentation and surgical outcome of aortic stenosis. Heart 2010; 96:539-45. [DOI: 10.1136/hrt.2009.186650] [Citation(s) in RCA: 105] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
241
|
Fuchs C, Pernicka E, Maurer G, Baumgartner H, Mascherbauer J. WOMEN RECEIVE SMALLER AORTIC VALVE PROSTHES THAN MEN - FOR ANATOMICAL REASONS? J Am Coll Cardiol 2010. [DOI: 10.1016/s0735-1097(10)60529-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
242
|
Mascherbauer J, Fuchs C, Stoiber M, Schima H, Pernicka E, Maurer G, Baumgartner H. Systemic pressure does not directly affect pressure gradient and valve area estimates in aortic stenosis in vitro. Eur Heart J 2008; 29:2049-57. [PMID: 18502739 DOI: 10.1093/eurheartj/ehn209] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
243
|
Mascherbauer J, Rosenhek R, Fuchs C, Pernicka E, Klaar U, Scholten C, Heger M, Wollenek G, Maurer G, Baumgartner H. Moderate patient-prosthesis mismatch after valve replacement for severe aortic stenosis has no impact on short-term and long-term mortality. Heart 2008; 94:1639-45. [PMID: 18450841 DOI: 10.1136/hrt.2008.142596] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
BACKGROUND The importance of moderate patient-prosthesis mismatch (PPM) for the prognosis of patients who undergo aortic valve replacement is unclear. METHODS The presence of PPM was assessed in 361 consecutive patients undergoing valve replacement for isolated severe aortic stenosis and related to perioperative and postoperative mortality. Indexed effective orifice areas (EOAi) were estimated for each type and size of prosthesis. RESULTS Using the previously proposed cut-off of EOAi <or=0.8 cm(2)/m(2), PPM was present in 54% of patients. Patients were followed for 4.1 (2.0) years. Survival tended to be slightly, but insignificantly, worse in the group with PPM (1-year, 3-year and 5-year survival 89%, 86% and 76% vs 92%, 88% and 82%; p = 0.21). However, patients with PPM were also older (p<0.0001), more often female (p<0.0001), more symptomatic (p = 0.001), more often had coronary artery disease (p = 0.04), triple vessel disease (p = 0.03) and hypertension (p = 0.01) and presented with a higher EuroSCORE (p<0.0001). By multivariate analysis only EuroSCORE and diabetes but not PPM were independent predictors of survival. CONCLUSIONS Moderate PPM is a frequent finding after aortic valve replacement. In our patient population it had no impact on short-term and long-term survival. It may therefore not be justified to recommend complex surgical interventions to avoid moderate PPM in patients undergoing aortic valve replacement for isolated severe aortic stenosis.
Collapse
|
244
|
Mascherbauer J, Rosenhek R, Bittner B, Binder J, Simon P, Maurer G, Schima H, Baumgartner H. Doppler Echocardiographic Assessment of Valvular Regurgitation Severity by Measurement of the Vena Contracta: An In Vitro Validation Study. J Am Soc Echocardiogr 2005; 18:999-1006. [PMID: 16198875 DOI: 10.1016/j.echo.2005.03.021] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/13/2004] [Indexed: 11/19/2022]
Abstract
BACKGROUND Noninvasive quantitation of valvular regurgitation remains a difficult problem. Measurements of the vena contracta (VC) by color Doppler echocardiography have been proposed but limited data are available on the actual accuracy of this method. METHODS To evaluate how closely the color Doppler VC reflects the true fluid dynamic VC and the anatomic regurgitant orifice and whether this measurement is affected by flow changes, various models of valvular regurgitation were studied in an in vitro flow circuit. The VC diameter was measured with color Doppler using two different ultrasound systems (Agilent Sonos 5500; Agilent Technologies Inc, Palo Alto, Calif and Vingmed CFM 800; GE Healthcare, Chalfront St Giles, UK). Optical planimetry of the anatomic regurgitant orifice was performed, the true VC diameter was determined by laser particle flow visualization. RESULTS Because of flow contraction, the true VC diameter was consistently smaller than the anatomic regurgitant orifice diameter. Anatomic orifice and true VC only marginally changed with flow rate. The diameter of the color Doppler VC, however, not only overestimated the anatomic orifice diameter by 45% to 60% and the true VC diameter by 130% to 160%, but was also highly affected by the flow rate and the ultrasound system. Despite these limitations a color Doppler VC diameter of 0.77 cm or more (Agilent) and 0.89 cm or more (Vingmed) detected severe regurgitation with a sensitivity of 93% and 84% and a specificity of 96% and 79%, respectively. CONCLUSIONS Color Doppler estimates of the VC markedly overestimate regurgitant orifice and true VC. In contrast to the true VC, Doppler measurements are significantly affected by flow rate and by the ultrasound system used. Nevertheless, they allow semiquantitative assessment of valvular regurgitation separating severe from nonsevere regurgitation with acceptable accuracy.
Collapse
|
245
|
Mascherbauer J, Schima H, Maurer G, Baumgartner H. Doppler assessment of mechanical aortic valve prostheses: effect of valve design and size of the aorta. THE JOURNAL OF HEART VALVE DISEASE 2004; 13:823-30. [PMID: 15473486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/30/2023]
Abstract
BACKGROUND AND AIM OF THE STUDY Discrepancies between Doppler and catheter gradients have been reported for bileaflet aortic valve prostheses. Whether modifications in geometric design of newly developed bileaflet valves lead to a different Doppler-catheter gradient relationship has not been evaluated. Variable results have been reported for tilting-disc prostheses. In addition, the effect of aortic size on the Doppler-catheter gradient relationship remains unclear. METHODS Various sizes of On-X and Edwards Mira (identical with Sorin Bicarbon) bileaflet valves and Sorin Allcarbon tilting-disc aortic valves (19-25 mm) were studied in a pulsatile flow model. Doppler and catheter gradients were measured simultaneously. Aortic diameters between 1.8 and 4 cm were evaluated. RESULTS Correlation between Doppler and catheter gradients was excellent (r = 0.98-0.99 for peak and mean gradients), but in bileaflet valves Doppler significantly overestimated the corresponding catheter gradients as reflected by slopes of the regression lines (1.57-1.8). In the range of relevant gradients > or = 10 mmHg, Doppler exceeded catheter gradients by 40 +/- 17% (peak) and 39 +/- 16% (mean) in Mira valves, and by 46 +/- 19% (peak) and 43 +/- 14% (mean) in On-X valves. In the Sorin tilting-disc valve, Doppler accurately reflected catheter gradients (slopes of regression lines 1.05-1.14). The aortic diameter significantly influenced results in only tilting-disc valves, but in absolute terms the effect was clinically less relevant. CONCLUSION Discrepancies between Doppler and catheter gradients are common to all bileaflet valves, regardless of their specific geometric design, whereas tilting-disc valves must be considered individually. The influence of aortic size on the Doppler-catheter gradient relationship appears clinically to be less relevant in prosthetic valves.
Collapse
|
246
|
Mascherbauer J, Schima H, Rosenhek R, Czerny M, Maurer G, Baumgartner H. Value and limitations of aortic valve resistance with particular consideration of low flow–low gradient aortic stenosis: an in vitro study. Eur Heart J 2004; 25:787-93. [PMID: 15120890 DOI: 10.1016/j.ehj.2004.02.011] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/26/2003] [Revised: 01/14/2004] [Accepted: 02/13/2004] [Indexed: 11/18/2022] Open
Abstract
BACKGROUND The calculation of valve resistance (R) rather than aortic valve area (AVA) has been proposed for the assessment of aortic stenosis (AS), based on the claim that it is less flow-dependent. Even more importantly, valve resistance has been reported to distinguish between truly severe and "pseudosevere" AS in patients with low cardiac output. However, the diagnostic value of valve resistance remains controversial. METHODS AND RESULTS Models of stenotic aortic valves (plates and nozzles) and biological stenotic valves were studied in a pulsatile in vitro circuit using Doppler ultrasound and direct pressure and flow measurements. Anatomic AVAs ranged from 0.5 to 1.25 cm2; cardiac output varied from 1.8 to 9.0 l/min. Effective AVA was calculated with the continuity equation. The orifices of the biological valves were recorded with a video camera for planimetry. In low flow-low gradient AS, truly severe stenosis was defined by an AVA remaining <0.85 cm2 after flow normalisation, whereas AVA increased beyond 0.85 cm2 in pseudosevere AS. In rigid stenoses, valve resistance increased significantly with flow, while in bioprostheses this flow dependence was partially masked by an actual increase of the anatomic orifice area. In low flow-low gradient AS, valve resistance was significantly smaller in pseudosevere AS compared to truly severe AS (129 +/- 28 vs. 176 +/- 33 dyne s cm(-5); p<0.001) at a similar baseline effective AVA. After the exclusion of datasets with mean gradients <15 and >35 mmHg, the difference in valve resistance between truly severe and pseudosevere AS was no longer significant (162 +/- 26 vs. 141 +/- 22 dyne s cm(-5); p=0.08). Nevertheless, valve resistance <120 dyne s cm(-5) was found only in pseudosevere stenoses while valve resistance >180 dyne s cm(-5) marked truly severe stenosis. CONCLUSIONS Valve resistance is flow-dependent and not superior to calculated AVA for the assessment of AS. In low flow-low gradient AS, valve resistance <120 dyne s cm(-5) identifies pseudosevere AS, whereas valve resistance >180 dyne s cm(-5) implies truly severe AS. However, values between 120 and 180 dyne s cm(-5) are nondiagnostic, requiring repeated AVA calculations after flow normalisation.
Collapse
|
247
|
Rosenhek R, Mascherbauer J, Huber L, Schima H, Maurer G. Doppler gradient estimations across tunnel obstructions: An in vitro study including flow visualization. J Am Coll Cardiol 2003. [DOI: 10.1016/s0735-1097(03)81359-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|